Developed meloxicam loaded microparticles for colon targeted delivery: Statistical optimization, physicochemical characterization, and in-vivo toxicity study

Abstract

The study aimed to fabricate and evaluate Meloxicam (MLX) loaded Hydroxypropyl Methylcellulose (HPMC) microparticles for colon targeting because MLX is a potent analgesic used in the treatment of pain and inflammation associated with colorectal cancer (CRC). Nevertheless, its efficiency is limited by poor solubility and gastrointestinal tracts (GIT) associated side effects. Seventeen formulations of MLX loaded HPMC microparticles were fabricated by the oil-in-oil (O/O)/ emulsion solvent evaporation (ESE) technique. A 3-factor, 3-level Box Behnken (BBD) statistical design was used to estimate the combined effects of the independent variables on the dependent variables (responses), such as the percent yield (R1), the entrapment efficiency (EE) (R2), mean particle size (R3) and in vitro percentage of cumulative drug release (R4). For physicochemical characterization FTIR, XRD, DSC, and SEM analyses were performed. Biocompatibility and non-toxicity were confirmed by in-vivo acute oral toxicity determination. The percentage yield and EE were 65.75–90.71%, and 70.62–88.37%, respectively. However, the mean particle size was 62.89–284.55 μm, and the in vitro cumulative drug release percentage was 74.25–92.64% for 24 hours. FTIR analysis showed that the composition of the particles was completely compatible, while XRD analysis confirmed the crystalline nature of the pure drug and its transition into an amorphous state after formulation. DSC analysis revealed the thermal stability of the formulations. The SEM analysis showed dense spherical particles. The toxicity study in albino rabbits showed no toxicity and was found biocompatible. The histopathological evaluation showed no signs of altered patterns. Results of this study highlighted a standard colonic drug delivery system with the ability to improve patient adherence and reduce GIT drug-associated side effects in CRC treatment.

Obliteration of H. pylori infection through the development of a novel thyme oil laden nanoporous gastric floating microsponge

“…Furthermore, in systems where the amount of DCM is constant, the same size pores are present in the microsponge structures and are uniformly distributed throughout the colloidal carrier. This intimate interaction in the pores facilitates the loading of essential oil in microsponges [ [26] , [27] , [28] ].…”

Colon Delivery of Nutraceutical Ingredients by Food-Grade Polymeric Systems: An Overview of Technological Characterization and Biological Evaluation

“…All these techniques synergistically allow the evaluation of the encapsulation process of the carrier substance [110]. For instance, absence of the characteristic peaks of the active substance in the spectra of the loaded system indicates its complete and uniform encapsulation in the carrier matrix.…”

Formulation and in vitro evaluation of meloxicam as a self-microemulsifying drug delivery system

“…This study aimed to prepare and characterize MLX as a liquid (SMEDDS) to improve its stability, solubility, and colloidal dispersibility for appropriate MLX delivery through the oral cavity, since according to biopharmaceutical classification system (BCS) parameters, MLX belongs to class II, which is of low solubility and high permeability. 4 …”